We must support vital research into PSP and CBD so that we can get answers for patients and ultimately find a cure.
Support vital research into Progressive Supranuclear Palsy and Corticobasal Degeneration to get answers for patients and ultimately find a cure.
Occurrences
“PSP is a heartbreaking condition that impacts thousands of Americans, including my dear friend and mentor Congresswoman Wexton. We must support vital research into PSP and CBD so that we can get answers for patients and ultimately find a cure. One way to make sure that happens is to bring awareness to this neurodegenerative disease and our resolution does just that,” said Rep. Subramanyam.
Evidence
The official House homepage's latest news section shows June 9, 2026 and June 8, 2026 items about gun-violence prevention bills, plus a May 26, 2026 Citibank letter; it does not show any PSP/CBD-specific research action in the lookback window.
The official caucus page lists Congressman Subramanyam as a member of the Rare Disease Caucus.
Assessments
The record provided does not show that Suhas Subramanyam delivered a concrete federal action specifically supporting research into Progressive Supranuclear Palsy or Corticobasal Degeneration, such as sponsoring legislation, securing funding, or publicly advancing a targeted research measure. The only affirmative evidence is his membership in the Rare Disease Caucus, which shows general alignment with rare-disease issues but is not enough to count this specific promise as fulfilled. At the same time, the absence of PSP/CBD-specific action in a limited recent lookback window is not strong enough to conclude the promise was definitively not delivered. On this record, the claim remains unresolved.